Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-25 @ 7:43 PM
Study NCT ID:
NCT00930735
Status:
UNKNOWN
Last Update Posted:
2018-04-23
First Post:
2009-06-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Prognostic Significance of Fibrosis Detection in Cardiomyopathy
Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Organization:
Study Overview
Official Title:
The Prognostic Significance of Fibrosis Detection in Ischemic and Non-ischemic Cardiomyopathy
Status:
UNKNOWN
Status Verified Date:
2018-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The presence of scar within heart muscle can act as a substrate for abnormal rhythm problems and lead to the developement of heart failure
Clinical significance Correlation with biomarkers and genetic markers
Clinical significance Correlation with biomarkers and genetic markers
Detailed Description:
Patients will undergo cardiovascular magnetic resonance (CMR) to include measurement of left ventricular volumes, ejection fraction, detection of inflammation (via STIR sequences) where appropriate, early gadolinium enhancement, late gadolinium enhancement, first pass perfusion using pharmacological stress imaging (contraindications to include comorbidities that do not permit pharmacological stress agents e.g. severe asthma, severe or symptomatic aortic stenosis)
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: